✦ LIBER ✦

Phase I trial of oral mTOR inhibitor everolimus in combination with trastuzumab and vinorelbine in pre-treated patients with HER2-overexpressing metastatic breast cancer

✍ Scribed by Guy Jerusalem; Angelica Fasolo; Veronique Dieras; Fatima Cardoso; Jonas Bergh; Luc Vittori; Yufen Zhang; Cristian Massacesi; Tarek Sahmoud; Luca Gianni

Publisher: Springer US
Year: 2010
Tongue: English
Weight: 326 KB
Volume: 125
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-010-1260-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I trial of oral metronomic vinor

A phase I trial of oral metronomic vinorelbine plus capecitabine in patients with metastatic breast cancer

✍ Zacharenia Saridaki; Nikolaos Malamos; Panagiotis Kourakos; Aristides Polyzos; A 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 294 KB

Phase II study of capecitabine and trast

Phase II study of capecitabine and trastuzumab combination chemotherapy in patients with HER2 overexpressing metastatic breast cancers resistant to both anthracyclines and taxanes

✍ Takanori Ishida; Takayoshi Kiba; Motohiro Takeda; Kotone Matsuyama; Satoshi Tera 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 367 KB

Multicenter phase II study of trastuzuma

Multicenter phase II study of trastuzumab in combination with epirubicin and docetaxel as first-line treatment for HER2-overexpressing metastatic breast cancer

✍ M. Venturini; C. Bighin; S. Monfardini; F. Cappuzzo; N. Olmeo; A. Durando; F. Pu 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 218 KB

Phase I dose finding study evaluating th

Phase I dose finding study evaluating the combination of bendamustine with weekly paclitaxel in patients with pre-treated metastatic breast cancer: RiTa trial

✍ Sibylle Loibl; Caroline Murmann; Katrin Schwedler; Mathias Warm; Lothar Müller; 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 326 KB

Phase II study of oral vinorelbine in co

Phase II study of oral vinorelbine in combination with capecitabine as second line chemotherapy in metastatic breast cancer patients previously treated with anthracyclines and taxanes

✍ Alison Jones; Mary O’Brien; Harald Sommer; Elzbieta Nowara; Anja Welt; Tadeusz P 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 364 KB

A phase I/II prospective, single arm tri

A phase I/II prospective, single arm trial of gefitinib, trastuzumab, and docetaxel in patients with stage IV HER-2 positive metastatic breast cancer

✍ G. Somlo; C. L. Martel; S. K. Lau; P. Frankel; C. Ruel; L. Gu; A. Hurria; C. Chu 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 229 KB